In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
Congenital diaphragmatic hernia (CDH) remains one of the most challenging neonatal conditions, associated with high morbidity and mortality due to the ...
Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results